A citation-based method for searching scientific literature

James L Januzzi, Shafiq U Rehman, Asim A Mohammed, Anju Bhardwaj, Linda Barajas, Justine Barajas, Han-Na Kim, Aaron L Baggish, Rory B Weiner, Annabel Chen-Tournoux, Jane E Marshall, Stephanie A Moore, William D Carlson, Gregory D Lewis, Jordan Shin, Dorothy Sullivan, Kimberly Parks, Thomas J Wang, Shawn A Gregory, Shanmugam Uthamalingam, Marc J Semigran. J Am Coll Cardiol 2011
Times Cited: 258







List of co-cited articles
1034 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
Matthias Pfisterer, Peter Buser, Hans Rickli, Marc Gutmann, Paul Erne, Peter Rickenbacher, André Vuillomenet, Urs Jeker, Paul Dubach, Hansjürg Beer,[...]. JAMA 2009
442
41

Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
G Michael Felker, Kevin J Anstrom, Kirkwood F Adams, Justin A Ezekowitz, Mona Fiuzat, Nancy Houston-Miller, James L Januzzi, Daniel B Mark, Ileana L Piña, Gayle Passmore,[...]. JAMA 2017
277
37

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.
Patrick Jourdain, Guillaume Jondeau, François Funck, Pascal Gueffet, Alain Le Helloco, Erwan Donal, Jean F Aupetit, Marie C Aumont, Michel Galinier, Jean C Eicher,[...]. J Am Coll Cardiol 2007
487
31

Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study.
Luc W M Eurlings, Petra E J van Pol, Wouter E Kok, Sandra van Wijk, Cara Lodewijks-van der Bolt, Aggie H M M Balk, Dirk J A Lok, Harry J G M Crijns, Dave J W van Kraaij, Nicolaas de Jonge,[...]. J Am Coll Cardiol 2010
146
30

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.
John G Lainchbury, Richard W Troughton, Kim M Strangman, Christopher M Frampton, Anna Pilbrow, Timothy G Yandle, Amjad K Hamid, M Gary Nicholls, A Mark Richards. J Am Coll Cardiol 2009
261
28

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.
R W Troughton, C M Frampton, T G Yandle, E A Espiner, M G Nicholls, A M Richards. Lancet 2000
28

N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
Rudolf Berger, Deddo Moertl, Sieglinde Peter, Roozbeh Ahmadi, Martin Huelsmann, Susan Yamuti, Brunhilde Wagner, Richard Pacher. J Am Coll Cardiol 2010
178
25

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
Alan S Maisel, Padma Krishnaswamy, Richard M Nowak, James McCord, Judd E Hollander, Philippe Duc, Torbjørn Omland, Alan B Storrow, William T Abraham, Alan H B Wu,[...]. N Engl J Med 2002
24

The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.
James L Januzzi, Carlos A Camargo, Saif Anwaruddin, Aaron L Baggish, Annabel A Chen, Daniel G Krauser, Roderick Tung, Renee Cameron, J Tobias Nagurney, Claudia U Chae,[...]. Am J Cardiol 2005
830
22

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Mark H Drazner, Gregg C Fonarow, Stephen A Geraci, Tamara Horwich, James L Januzzi,[...]. J Am Coll Cardiol 2013
22

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis.
Richard W Troughton, Christopher M Frampton, Hans-Peter Brunner-La Rocca, Matthias Pfisterer, Luc W M Eurlings, Hans Erntell, Hans Persson, Christopher M O'Connor, Deddo Moertl, Patric Karlström,[...]. Eur Heart J 2014
183
22

Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
21

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
21

The STARBRITE trial: a randomized, pilot study of B-type natriuretic peptide-guided therapy in patients with advanced heart failure.
Monica R Shah, Robert M Califf, Anju Nohria, Manju Bhapkar, Margaret Bowers, Donna M Mancini, Mona Fiuzat, Lynne W Stevenson, Christopher M O'Connor. J Card Fail 2011
98
19

Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure.
G Michael Felker, Tariq Ahmad, Kevin J Anstrom, Kirkwood F Adams, Lawton S Cooper, Justin A Ezekowitz, Mona Fiuzat, Nancy Houston-Miller, James L Januzzi, Eric S Leifer,[...]. JACC Heart Fail 2014
102
19

NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.
James L Januzzi, Roland van Kimmenade, John Lainchbury, Antoni Bayes-Genis, Jordi Ordonez-Llanos, Miguel Santalo-Bel, Yigal M Pinto, Mark Richards. Eur Heart J 2006
733
18

Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.
Mark Ledwidge, Joseph Gallagher, Carmel Conlon, Elaine Tallon, Eoin O'Connell, Ian Dawkins, Chris Watson, Rory O'Hanlon, Margaret Bermingham, Anil Patle,[...]. JAMA 2013
341
18


Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).
Serge Masson, Roberto Latini, Inder S Anand, Simona Barlera, Laura Angelici, Tarcisio Vago, Gianni Tognoni, Jay N Cohn. J Am Coll Cardiol 2008
250
17

Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
Michael R Zile, Brian L Claggett, Margaret F Prescott, John J V McMurray, Milton Packer, Jean L Rouleau, Karl Swedberg, Akshay S Desai, Jianjian Gong, Victor C Shi,[...]. J Am Coll Cardiol 2016
194
17

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Monica M Colvin, Mark H Drazner, Gerasimos S Filippatos, Gregg C Fonarow, Michael M Givertz,[...]. J Am Coll Cardiol 2017
16

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
G Michael Felker, Vic Hasselblad, Adrian F Hernandez, Christopher M O'Connor. Am Heart J 2009
242
15

B-type natriuretic peptide-guided heart failure therapy: A meta-analysis.
Pramote Porapakkham, Pornwalee Porapakkham, Hendrik Zimmet, Baki Billah, Henry Krum. Arch Intern Med 2010
214
15

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.
Paulo Bettencourt, Ana Azevedo, Joana Pimenta, Fernando Friões, Susana Ferreira, António Ferreira. Circulation 2004
534
15


Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
James L Januzzi, Rahul Sakhuja, Michelle O'donoghue, Aaron L Baggish, Saif Anwaruddin, Claudia U Chae, Renee Cameron, Daniel G Krauser, Roderick Tung, Carlos A Camargo,[...]. Arch Intern Med 2006
186
14

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).
Inder S Anand, Lloyd D Fisher, Yann-Tong Chiang, Roberto Latini, Serge Masson, Aldo P Maggioni, Robert D Glazer, Gianni Tognoni, Jay N Cohn. Circulation 2003
643
14

Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure.
Hanna K Gaggin, Jackie Szymonifka, Anju Bhardwaj, Arianna Belcher, Benedetta De Berardinis, Shweta Motiwala, Thomas J Wang, James L Januzzi. JACC Heart Fail 2014
156
14

Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials.
Gianluigi Savarese, Bruno Trimarco, Santo Dellegrottaglie, Maria Prastaro, Francesco Gambardella, Giuseppe Rengo, Dario Leosco, Pasquale Perrone-Filardi. PLoS One 2013
112
13

Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study.
James L Januzzi, W Frank Peacock, Alan S Maisel, Claudia U Chae, Robert L Jesse, Aaron L Baggish, Michelle O'Donoghue, Rahul Sakhuja, Annabel A Chen, Roland R J van Kimmenade,[...]. J Am Coll Cardiol 2007
370
13

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction.
Rudolf A de Boer, Dirk J A Lok, Tiny Jaarsma, Peter van der Meer, Adriaan A Voors, Hans L Hillege, Dirk J van Veldhuisen. Ann Med 2011
422
13

Soluble concentrations of the interleukin receptor family member ST2 and β-blocker therapy in chronic heart failure.
Hanna K Gaggin, Shweta Motiwala, Anju Bhardwaj, Kimberly A Parks, James L Januzzi. Circ Heart Fail 2013
98
13

Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
Sheryl L Chow, Alan S Maisel, Inder Anand, Biykem Bozkurt, Rudolf A de Boer, G Michael Felker, Gregg C Fonarow, Barry Greenberg, James L Januzzi, Michael S Kiernan,[...]. Circulation 2017
314
13

Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study.
Rory B Weiner, Aaron L Baggish, Annabel Chen-Tournoux, Jane E Marshall, Hanna K Gaggin, Anju Bhardwaj, Asim A Mohammed, Shafiq U Rehman, Linda Barajas, Justine Barajas,[...]. Eur J Heart Fail 2013
56
21

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur J Heart Fail 2016
12

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
Gregg C Fonarow, William F Peacock, Christopher O Phillips, Michael M Givertz, Margarita Lopatin. J Am Coll Cardiol 2007
359
12

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
Milton Packer, John J V McMurray, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. Circulation 2015
447
12

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Monica M Colvin, Mark H Drazner, Gerasimos S Filippatos, Gregg C Fonarow, Michael M Givertz,[...]. Circulation 2017
12

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.
John J V McMurray, Stamatis Adamopoulos, Stefan D Anker, Angelo Auricchio, Michael Böhm, Kenneth Dickstein, Volkmar Falk, Gerasimos Filippatos, Cândida Fonseca, Miguel Angel Gomez-Sanchez,[...]. Eur Heart J 2012
11

Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.
Hans-Peter Brunner-La Rocca, Luc Eurlings, A Mark Richards, James L Januzzi, Matthias E Pfisterer, Ulf Dahlström, Yigal M Pinto, Patric Karlström, Hans Erntell, Rudolf Berger,[...]. Eur J Heart Fail 2015
69
14


Biomarkers in heart failure.
Eugene Braunwald. N Engl J Med 2008
892
10

Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Antoni Bayes-Genis, Marta de Antonio, Joan Vila, Judith Peñafiel, Amparo Galán, Jaume Barallat, Elisabet Zamora, Agustin Urrutia, Josep Lupón. J Am Coll Cardiol 2014
180
10

A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
Khibar Salah, Wouter E Kok, Luc W Eurlings, Paulo Bettencourt, Joana M Pimenta, Marco Metra, Antoni Bayes-Genis, Valerio Verdiani, Luca Bettari, Valentina Lazzarini,[...]. Heart 2014
86
11

PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial.
Martin Huelsmann, Stephanie Neuhold, Michael Resl, Guido Strunk, Helmut Brath, Claudia Francesconi, Christopher Adlbrecht, Rudolf Prager, Anton Luger, Richard Pacher,[...]. J Am Coll Cardiol 2013
181
10

Natriuretic peptide-guided heart failure management.
Richard Troughton, G Michael Felker, James L Januzzi. Eur Heart J 2014
132
9


Cardiac troponin and outcome in acute heart failure.
W Frank Peacock, Teresa De Marco, Gregg C Fonarow, Deborah Diercks, Janet Wynne, Fred S Apple, Alan H B Wu. N Engl J Med 2008
496
9

Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.
Roland R van Kimmenade, James L Januzzi, Patrick T Ellinor, Umesh C Sharma, Jaap A Bakker, Adrian F Low, Abelardo Martinez, Harry J Crijns, Calum A MacRae, Paul P Menheere,[...]. J Am Coll Cardiol 2006
421
9

Prognostic value of soluble ST2 in the Valsartan Heart Failure Trial.
Inder S Anand, Thomas S Rector, Michael Kuskowski, James Snider, Jay N Cohn. Circ Heart Fail 2014
98
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.